Clinical Trials Browser

Phase 1 × NIH × raltitrexed × Clear all

NCT00003528 2013-01-16

Raltitrexed in Treating Children With Refractory Acute Leukemia

Phase 1 Completed

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00001341 2008-03-04

A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease

Phase 1 Completed

Neoplasms